The epigenetic silencing of MGMT is frequently debated as a clinical biomarker30 and previous work revealed that JQ1 disturbs DNA damage responses by attenuating MGMT expression in glioblastoma cells31. This evidence concerns the gene MGMT and glioblastoma.